Prospects of Synchronous fMRI-EEG Recording as the Basis for Neurofeedback (Exemplified on Patient with Stroke Sequelae)
- Авторлар: Savelov A.1, Shtark M.2,3,4, Mel’nikov M.2,3, Kozlova L.2,3, Bezmaternykh D.2,3, Verevkin E.2, Petrovskii E.1, Pokrovskii M.1, Tsirkin G.2, Rudych P.5
-
Мекемелер:
- International Tomography Center, Siberian Division of the Russian Academy of Sciences
- Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine
- Novosibirsk National Research State University
- Research-and-Development Enterprise Komsib
- Institute of Computational Technologies, Siberian Division of the Russian Academy of Sciences
- Шығарылым: Том 166, № 3 (2019)
- Беттер: 390-393
- Бөлім: Experimental Methods for Clinical Practice
- URL: https://journals.rcsi.science/0007-4888/article/view/241029
- DOI: https://doi.org/10.1007/s10517-019-04357-8
- ID: 241029
Дәйексөз келтіру
Аннотация
Synchronous fMRI-EEG mapping of cerebral activity in stroke patients made it possible to implement neurofeedback, a novel and promising therapeutic technology. This method integrates a real-time monitoring of cerebral activity by EEG and fMRI signals and training of the patients to control this activity simultaneously or alternatively via neurofeedback. The targets of such cerebral stimulation are cortical regions controlling arbitrary movements (Brodmann area 4), whereas its aim is optimization of activity in these regions in order to achieve better rehabilitation of stroke patients. The paper discusses the methodical details, advantages, and promise of bimodal neurofeedback treatment.
Авторлар туралы
A. Savelov
International Tomography Center, Siberian Division of the Russian Academy of Sciences
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk
M. Shtark
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine; Novosibirsk National Research State University; Research-and-Development Enterprise Komsib
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk; Novosibirsk; Novosibirsk
M. Mel’nikov
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine; Novosibirsk National Research State University
Хат алмасуға жауапты Автор.
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk; Novosibirsk
L. Kozlova
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine; Novosibirsk National Research State University
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk; Novosibirsk
D. Bezmaternykh
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine; Novosibirsk National Research State University
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk; Novosibirsk
E. Verevkin
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk
E. Petrovskii
International Tomography Center, Siberian Division of the Russian Academy of Sciences
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk
M. Pokrovskii
International Tomography Center, Siberian Division of the Russian Academy of Sciences
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk
G. Tsirkin
Research Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk
P. Rudych
Institute of Computational Technologies, Siberian Division of the Russian Academy of Sciences
Email: mikhailmelnikov@mail.ru
Ресей, Novosibirsk